These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26160719)

  • 21. Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.
    de Schepper J; Hachimi-Idrissi S; Louis O; Maurus R; Otten J
    Arch Dis Child; 1994 Oct; 71(4):346-8. PubMed ID: 7979531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy.
    Tekgul H; Serdaroglu G; Huseyinov A; Gökben S
    J Child Neurol; 2006 May; 21(5):411-4. PubMed ID: 16901447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: A prospective study.
    Shi KL; Guo JX; Zhao HM; Hong H; Yang CZ; Wu YH; Du LJ
    Epilepsy Behav; 2020 Dec; 113():107555. PubMed ID: 33242769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of new antiseizure medication on bone metabolism and bone mineral density in children: A meta-analysis.
    Zhuo L; Zhang Y
    Front Pediatr; 2022; 10():1015691. PubMed ID: 36458136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractures, epilepsy, and antiepileptic drugs.
    Mattson RH; Gidal BE
    Epilepsy Behav; 2004 Feb; 5 Suppl 2():S36-40. PubMed ID: 15123010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of oxcarbazepine on bone metabolism.
    Cetinkaya Y; Kurtulmuş YS; Tutkavul K; Tireli H
    Acta Neurol Scand; 2009 Sep; 120(3):170-5. PubMed ID: 19719808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.
    Pack AM; Morrell MJ; Marcus R; Holloway L; Flaster E; Doñe S; Randall A; Seale C; Shane E
    Ann Neurol; 2005 Feb; 57(2):252-7. PubMed ID: 15668966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
    Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
    Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
    Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
    Serin HM; Koç ZP; Temelli B; Esen İ
    Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density, vitamin D and osseous metabolism indices in neurofibromatosis type 1: A systematic review and meta-analysis.
    Kaspiris A; Vasiliadis E; Iliopoulos ID; Panagopoulos F; Melissaridou D; Lianou I; Ntourantonis D; Savvidou OD; Papadimitriou E; Pneumaticos SG
    Bone; 2024 Mar; 180():116992. PubMed ID: 38141750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis.
    Wang A; Wang Y; Liu H; Hu X; Li J; Xu H; Nie Z; Zhang L; Lyu Z
    Front Endocrinol (Lausanne); 2022; 13():1027841. PubMed ID: 36387892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone disease induced by phenytoin therapy: clinical and experimental study.
    Moro-Alvarez MJ; Díaz Curiel M; de la Piedra C; Mariñoso ML; Carrascal MT
    Eur Neurol; 2009; 62(4):219-30. PubMed ID: 19628941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ; Lin KL; Wang HS; Wang CJ
    Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive bone deficit in epilepsy.
    Sheth RD; Binkley N; Hermann BP
    Neurology; 2008 Jan; 70(3):170-6. PubMed ID: 18057319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of zonisamide monotherapy on bone health in drug-naive epileptic patients.
    Koo DL; Nam H
    Epilepsia; 2020 Oct; 61(10):2142-2149. PubMed ID: 32944954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of valproate on bone mineral density in adult epileptic patients.
    Boluk A; Guzelipek M; Savli H; Temel I; Ozişik HI; Kaygusuz A
    Pharmacol Res; 2004 Jul; 50(1):93-7. PubMed ID: 15082034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment for osteoporosis in people with ß-thalassaemia.
    Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
    Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies.
    Min L; Chunyan W; Biaoxue R
    BMC Pediatr; 2020 Mar; 20(1):97. PubMed ID: 32122313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.